U.S. FDA approves coronavirus vaccines engineered for Omicron variant

The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a broad fall vaccination campaign that could begin within days. The new vaccines also include the original version of the virus targeted by all… Read More U.S. FDA approves coronavirus vaccines engineered for Omicron variant

Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant

Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine retooled to target the Omicron variant. The request to the Food and Drug Administration was for a so-called bivalent vaccine containing the dominant BA.4/BA.5 variants of the virus along with the original coronavirus strain. It is intended… Read More Pfizer seeks U.S. authorization for coronavirus vaccine engineered to tackle Omicron variant

Britain approves vaccine to tackle Omicron coronavirus variant

Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus. The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by U.S. drug company Moderna conditional approval as a… Read More Britain approves vaccine to tackle Omicron coronavirus variant